PK

Prakashbhai Kalubhai Goti

Active Director Director DIN 06762405
DIN 06762405 First appointment Jan 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 2014
Shareholding value •••• Premium profile

About Prakashbhai Kalubhai Goti

Data last updated:

Prakashbhai Kalubhai Goti is a Director at Janveda Healthceutical Private Limited (since 2026), Director at Janveda Formulation Private Limited (since 2019) and Designated Partner at Hy-Genex Chemicals Llp (since 2021), and holds 1 more current directorship. The companies operate in Pharma, Chemicals and Non-Profit Organizations. The 2 current companies with reported revenue have a combined latest revenue of ₹7.04 Cr; the largest is Janveda Healthceutical Private Limited at ₹6.76 Cr (FY 2024). Earlier, Prakashbhai Kalubhai Goti was a Director at Piecan Pharma Private Limited (2016–2019) and Director at Basil Life Sciences Private Limited (2014).

DIN 06762405
Primary Designation Director
Industry Pharma
First Appointment 22 Jan 2014
Oldest Company Age 7 yrs
Largest company Janveda Healthceutical Private Limited · ₹6.76 Cr (FY 2024)
Combined revenue ₹7.04 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jan 20262021₹6.76 Cr (FY 2024)Active
Janveda Formulation Private Limited U74999GJ2019PTC105848
Director03 Jan 20192019₹27.9 Lakh (FY 2025)Active
Designated Partner20 Jan 20212021Active
Janveda Federation U85300GJ2019NPL107293
Director28 Mar 20192019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Piecan Pharma Private Limited U24299GJ2016PTC092261
Director31 May 20162016₹5.52 Cr (FY 2023)Active
Basil Life Sciences Private Limited U24232GJ2014PTC078374
Director22 Jan 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Prakashbhai Kalubhai Goti

Directorship timeline

Open interactive timeline →
Hy-Genex Chemicals Llp
Janveda Formulation Private Limited
Janveda Federation
Janveda Healthceutical Private Limited
Premium access

Shareholding and investment profile for Prakashbhai Kalubhai Goti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prakashbhai Kalubhai Goti

Prakashbhai Kalubhai Goti currently holds 4 directorships: Janveda Healthceutical Private Limited (Director, since 19 Jan 2026, revenue ₹6.76 Cr (FY 2024)); Janveda Formulation Private Limited (Director, since 03 Jan 2019, revenue ₹27.9 Lakh (FY 2025)); Hy-Genex Chemicals Llp (Designated Partner, since 20 Jan 2021); Janveda Federation (Director, since 28 Mar 2019).

Prakashbhai Kalubhai Goti was first appointed on 22 Jan 2014 as Director at Basil Life Sciences Private Limited. The most recent appointment on record is 19 Jan 2026 at Janveda Healthceutical Private Limited.

The 2 current companies of Prakashbhai Kalubhai Goti that report revenue have a combined latest revenue of ₹7.04 Cr: Janveda Healthceutical Private Limited ₹6.76 Cr (FY 2024); Janveda Formulation Private Limited ₹27.9 Lakh (FY 2025).

Prakashbhai Kalubhai Goti held 2 earlier board appointments: Piecan Pharma Private Limited (Director, 31 May 2016 to 12 Feb 2019); Basil Life Sciences Private Limited (Director, 22 Jan 2014 to 31 Mar 2014).

The current boards of Prakashbhai Kalubhai Goti's companies include Tusharbhai Babubhai Mangukiya (Janveda Healthceutical Private Limited), Geet Shah (Hy-Genex Chemicals Llp), Krunal Rajendrakumar Shah (Hy-Genex Chemicals Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available